China Pharma Holdings (CPHI) Payables (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Payables came in at $2.3 million in Q1 2026, down 30.29% YoY from $3.3 million in Q1 2025, and down 0.99% on a QoQ basis from $2.3 million in Q4 2025.
China Pharma Holdings (CPHI) Payables (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Payables data on file, last reported at $2.3 million in Q1 2026.
- Quarterly Payables fell 30.29% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 30.29% YoY) and the FY2025 annual result came in at $2.3 million, down 30.1% from the prior year.
- Payables retreated to $2.3 million in Q1 2026, from $2.3 million in the prior quarter.
- In the past five years, Payables ranged from a high of $6.2 million in Q4 2022 to a low of $338414.0 in Q1 2022.
- A 5-year average of $2.5 million and a median of $2.3 million in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables slumped 88.54% — and 2023, when it soared 1082.54%.
- Tracing CPHI's Payables over 5 years: stood at $6.2 million in 2022, then plunged by 66.07% to $2.1 million in 2023, then surged by 58.46% to $3.3 million in 2024, then tumbled by 30.1% to $2.3 million in 2025, then slipped by 0.99% to $2.3 million in 2026.
- The last three Payables figures came in at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 986.00 Mn |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | 4.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | 2.33 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 3.30 Mn |
| Dec 31, 2024 | 3.33 Mn |
| Sep 30, 2024 | 705,667.00 |
| Jun 30, 2024 | 551,451.00 |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 2.10 Mn |
| Sep 30, 2023 | 2.57 Mn |
| Jun 30, 2023 | 2.76 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 6.19 Mn |
| Sep 30, 2022 | 4.91 Mn |
| Jun 30, 2022 | 349,805.00 |
| Mar 31, 2022 | 338,414.00 |
| Dec 31, 2021 | 841,622.00 |
| Sep 30, 2021 | 1.73 Mn |
| Jun 30, 2021 | 3.05 Mn |